Events
Biologics World Nordics 2025
Date: 5-6 March
Location: Stockholm, Sweden
Guro Gafvelin, the Chief Technology Officer at NEOGAP Therapeutics, will deliver a presentation on personalised T-cell therapies for cancer at Biologics World Nordics 2025. Her talk will highlight our innovative cell therapy approach, showcasing our commitment to advancing cancer treatment. We invite you to engage with Guro, as well as her colleagues Andrea Salmén, Chief Operating Officer, and Kristine Bylund, Head of Cell Therapy Production and Development, during the event to discuss our cutting-edge cancer therapy and explore potential investment opportunities and partnership possibilities.
More information at Biologics World Nordics 2025.
Swiss Nordic Bio 2025
Date: 13 March
Location: Zurich, Switzerland
We are thrilled to announce our participation in Swiss Nordic Bio, a premier event connecting biotech, pharmaceutical, and healthtech companies with top investors and industry leaders. This exclusive opportunity allows us to showcase our innovative therapy, engage in face-to-face meetings with potential investors and partners. We look forward to forging valuable connections and exploring new avenues for collaboration in the dynamic healthcare landscape.
More information at Swiss Nordic Bio.
Previous events
ATMP Sweden 2024
Date: 25-26 November
Location: Malmö, Sweden
NEOGAP will participate in the annual ATMP Sweden conference in Malmö, where we will engage with peers to discuss advancements in therapeutics. We are excited to present our latest developments in the poster titled “A first in human Phase I/IIa trial of personalised Tumour-Trained Lymphocytes, pTTL, derived from regional lymph nodes for treatment of colorectal cancer”.
More information at ATMP Sweden.
SITC 2024
Date: 6-10 November
Location: Houston, U.S.
We will be at the Society for Immunotherapy of Cancer (SITC) Conference to showcase our poster “Personalized Tumor-Trained Lymphocytes – A neoantigen targeted T cell therapy product for treatment of colorectal cancer”.
Guro Gafvelin, our Chief Technology Officer, and Sofia Berglund, Principal Scientist Clinical Development, will be there to connect and discuss deeper insights.
More information at SITC 2024.
BIO-Europe 2024
Date: 4-6 November
Location: Stockholm, Sweden
Andrea Salmén, Chief Operating Officer, and Ola Nilsson, Head of Neoantigen Production & Development, will be there to discuss advances in immuno-oncology and explore partnerships for our innovative cell therapy program.
More information at BIO-Europe.